Prospective randomized comparison of 2 different methods of 5% povidone-iodine applications for anterior segment intraocular surgery.
OBJECTIVE
To determine the efficacy of reducing conjunctival bacteria flora with 2 different regimens of 5% povidone-iodine application: 2 drops on the conjunctiva cul-de-sac vs a 10-mL conjunctival irrigation of the fornices.


METHODS
In this prospective controlled trial, 200 eyes undergoing anterior segment intraocular surgery were randomized to control and study groups. All patients from both groups received topical ofloxacin and a povidone-iodine scrub of the periorbital area before the surgical procedure. The eyes in the control group received 2 drops of povidone-iodine on the conjunctiva preoperatively, whereas eyes in the study group had irrigation of the fornices with 10 mL of povidone-iodine. Conjunctival cultures were obtained at 4 separate time points before and after surgery.


RESULTS
Twenty (26%) of 78 eyes in the study group had positive conjunctival cultures immediately prior to surgery compared with 40 (43%) of 94 eyes in the control group (P = .02). At the conclusion of the surgery, 14 (18%) of 78 eyes and 30 (32%) of 94 eyes had positive cultures in the study and control groups, respectively (P = .05).


CONCLUSIONS
Irrigation of the fornices with 5% povidone-iodine was associated with significantly fewer positive conjunctival cultures at the time of surgery compared with the application of 2 drops on the conjunctiva.
Miño de Kaspar
Herminia
H
Department of Ophthalmology, Ludwig-Maximilians University, Munich, Germany.
Chang
Robert T
RT
Singh
Kuldev
K
Egbert
Peter R
PR
Blumenkranz
Mark S
MS
Ta
Christopher N
CN
D000368:Aged; D000869:Anterior Eye Segment / Q000601:surgery*; D000900:Anti-Bacterial Agents / Q000008:administration & dosage; D000891:Anti-Infective Agents, Local / Q000008:administration & dosage*; D001082:Aqueous Humor / Q000382:microbiology; D001419:Bacteria / Q000302:isolation & purification*; D015169:Colony Count, Microbial; D003228:Conjunctiva / Q000382:microbiology*; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008297:Male; D015242:Ofloxacin / Q000008:administration & dosage; D009883:Ophthalmic Solutions; D011206:Povidone-Iodine / Q000008:administration & dosage*; D011446:Prospective Studies; D007507:Therapeutic Irrigation
D000900:Anti-Bacterial Agents; D000891:Anti-Infective Agents, Local; D009883:Ophthalmic Solutions; D011206:Povidone-Iodine; D015242:Ofloxacin